The role of N-methyl-d-aspartate receptors in dopaminergic neuropathology produced by the amphetamines

Baldwin, 1993, Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine, Br. J. Pharmacol., 108, 590, 10.1111/j.1476-5381.1993.tb12847.x Cohen, 1984, Oxy-radical toxicity in catecholamine neurons, Neurotoxicology, 5, 77 Colado, 1993, 5-HT loss in rat brain following 3,4-methylenedioxy-methamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine, Br. J. Pharmacol., 108, 583, 10.1111/j.1476-5381.1993.tb12846.x Dykens, 1987, Mechanism of kainate toxicity to cerebellar neurons in vitro is analogous to reperfusion tissue injury, J. Neurochem., 49, 1222, 10.1111/j.1471-4159.1987.tb10014.x Ellison, 1978, Longterm changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration, Science, 201, 276, 10.1126/science.26975 Finnegan, 1990, The N-methyl-d-aspartate (NMDA) receptor antagonist, dextrorphan, prevents the neurotoxic effects of 3,4-methylenedioxy-methamphetamine (MDMA) in rats, Neurosci. Lett., 105, 300, 10.1016/0304-3940(89)90637-X Fuller, 1980, Long-lasting depletion of striatal dopamine by a single injection of amphetamine in iprindole-treated rats, Science, 209, 305, 10.1126/science.7384808 Green, 1992, The neurotoxic effects of methamphetamine on 5-hydroxytryptamine and dopamine in brain: evidence for the protective effect of chlormethiazole, Neuropharmacology, 31, 315, 10.1016/0028-3908(92)90062-T Henderson, 1992, MK-801 protects against amphetamine-induced striatal dopamine depletion in iprindole-treated rats, but not against brain serotonin depletion after p-chloroamphetamine, Ann. N.Y. Acad. Sci., 648, 286, 10.1111/j.1749-6632.1992.tb24558.x Hotchkiss, 1980, Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity on rat brain, J. Pharmacol. Exp. Ther., 214, 257 Hotchkiss, 1979, The long-term effects of multiple doses of methamphetamine on neostriatal tryptophan hydroxylase, tyrosine hydroxylase, choline acetyltransferase and glutamate decarboxylase activities, Life Sci., 25, 1373, 10.1016/0024-3205(79)90414-4 Jonsson, 1982, Selective (+)-amphetamine neurotoxicity on striatal dopamine nerve terminals in the mouse, Br. J. Pharmacol., 77, 335, 10.1111/j.1476-5381.1982.tb09303.x Meldrum, 1991, Excitatory amino acid neurotoxicity and neurodegenerative disease, TIPS Special Report, 54 Nash, 1992, Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxy-methamphetamine, Brain Res., 581, 237, 10.1016/0006-8993(92)90713-J Pellegrini-Giampietro, 1988, Excitatory amino acid release from rat hippocampal slices as a consequence of free-radical formation, J. Neurochem., 51, 1960, 10.1111/j.1471-4159.1988.tb01187.x Preston, 1985, Long-term effects of repeated methylamphetamine administration on monoamine neurons in the rhesus monkey brain, Brain Res., 338, 243, 10.1016/0006-8993(85)90153-2 Ricaurte, 1992, Lasting effects of (±)-3,4-methylenedioxy-methamphetamine (MDMA) on central serotonergic neurons in non-human primates: neurochemical observations, J. Pharmacol. Exp. Ther., 261, 616 Schmidt, 1987, Acute administration of methylenedioxy-methamphetamine: comparison with the neurochemical effects of its N-desmethyl and N-ethyl analogs, Eur. J. Pharmacol., 136, 81, 10.1016/0014-2999(87)90782-5 Schmidt, 1986, Methylenedioxy-methamphetamine: a potentially neurotoxic amphetamine analogue, Eur. J. Pharmacol., 124, 175, 10.1016/0014-2999(86)90140-8 Seeburg, 1993, The molecular biology of mammalian glutamate receptor channels, TIPS, 14, 297 Seiden, 1984, Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single dose of methylamphetamine, Pharmacol. Biochem. Behav., 21, 29, 10.1016/0091-3057(84)90125-4 Sonsalla, 1992, Characteristics of dopaminergic neurotoxicity produced by MPTP and methamphetamine, Ann. N.Y. Acad. Sci., 648, 229, 10.1111/j.1749-6632.1992.tb24542.x Sonsalla, 1987, Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and methamphetamine in several strains of mice, Prog. Neuropsychopharmacol. Biol. Psychiatr., 12, 345, 10.1016/0278-5846(88)90054-1 Sonsalla, 1989, Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity, Science, 243, 398, 10.1126/science.2563176 Sonsalla, 1991, Competitive and non-competitive antagonists at N-methyl-d-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice, J. Pharmacol. Exp. Ther., 256, 506 Weihmuller, 1992, MK-801 protection against methamphetamine-induced striatal dopamine terminal injury is associated with attenuated dopamine overflow, Synapse, 11, 155, 10.1002/syn.890110209 Zeevalk, 1992, Evidence that the loss of voltage-dependent Mg2+ block at the N-methly-d-aspartate receptor underlies receptor activation during inhibition of neuronal metabolism, J. Neurochem., 59, 1211, 10.1111/j.1471-4159.1992.tb08430.x